These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28233887)

  • 1. The pathobiology and treatment of Hodgkin lymphoma. Where do we go from Gianni Bonadonna's lesson?
    Viviani S; Tabanelli V; Pileri SA
    Tumori; 2017 Mar; 103(2):101-113. PubMed ID: 28233887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodular lymphocyte predominant Hodgkin lymphoma.
    Lee AI; LaCasce AS
    Oncologist; 2009 Jul; 14(7):739-51. PubMed ID: 19605845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Febrile cholestatic disease as an initial presentation of nodular lymphocyte-predominant Hodgkin lymphoma.
    Mrzljak A; Gasparov S; Kardum-Skelin I; Colic-Cvrlje V; Ostojic-Kolonic S
    World J Gastroenterol; 2010 Sep; 16(35):4491-3. PubMed ID: 20845519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard therapies versus novel therapies in Hodgkin lymphoma.
    Gallamini A; Di Raimondo F; La Nasa G; Romano A; Borra A; Greco M
    Immunol Lett; 2013; 155(1-2):56-9. PubMed ID: 24140162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?
    Fanale M
    Hematology Am Soc Hematol Educ Program; 2013; 2013():406-13. PubMed ID: 24319212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma.
    McKay P; Fielding P; Gallop-Evans E; Hall GW; Lambert J; Leach M; Marafioti T; McNamara C;
    Br J Haematol; 2016 Jan; 172(1):32-43. PubMed ID: 26538004
    [No Abstract]   [Full Text] [Related]  

  • 7. Nodular Lymphocyte-Predominant Hodgkin Lymphoma in a Warthin Tumor of the Parotid Gland: A Case Report and Literature Review.
    Di Napoli A; Mallel G; Bartolazzi A; Cavalieri E; Becelli R; Cippitelli C; Ruco L
    Int J Surg Pathol; 2015 Aug; 23(5):419-23. PubMed ID: 26169920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Intrafollicular neoplasia" of nodular lymphocyte predominant Hodgkin lymphoma: description of a hypothetic early step of the disease.
    Carbone A; Gloghini A
    Hum Pathol; 2012 May; 43(5):619-28. PubMed ID: 22209342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management.
    Ansell SM
    Am J Hematol; 2012 Dec; 87(12):1096-103. PubMed ID: 23151980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the initial management of Hodgkin's Lymphoma.
    Marri PR; Ansell SM
    Transfus Apher Sci; 2013 Aug; 49(1):12-8. PubMed ID: 23769695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group.
    Nogová L; Reineke T; Brillant C; Sieniawski M; Rüdiger T; Josting A; Bredenfeld H; Skripnitchenko R; Müller RP; Müller-Hermelink HK; Diehl V; Engert A;
    J Clin Oncol; 2008 Jan; 26(3):434-9. PubMed ID: 18086799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's lymphoma: molecular targets and novel treatment strategies.
    Yazbeck V; Georgakis GV; Wedgwood A; Younes A
    Future Oncol; 2006 Aug; 2(4):533-51. PubMed ID: 16922620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathological diagnosis of Hodgkin lymphoma].
    Tamaru J
    Nihon Rinsho; 2014 Mar; 72(3):450-5. PubMed ID: 24724402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composite lymphoma of nodular lymphocyte-predominant and classical Hodgkin lymphoma-Epstein-Barr virus association suggests divergent pathogenesis despite clonal relatedness.
    Szczepanowski M; Masqué-Soler N; Oschlies I; Schmidt W; Lück A; Klapper W
    Hum Pathol; 2013 Jul; 44(7):1434-9. PubMed ID: 23427872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma.
    Saarinen S; Pukkala E; Vahteristo P; Mäkinen MJ; Franssila K; Aaltonen LA
    J Clin Oncol; 2013 Mar; 31(7):938-43. PubMed ID: 23284040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Hodgkin lymphoma.
    Ansell SM; Armitage JO
    Mayo Clin Proc; 2006 Mar; 81(3):419-26. PubMed ID: 16529147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?
    Barber NA; Loberiza FR; Perry AM; Bast M; Holdeman KP; Esfahane AB; Weisenburger DD; Vose J; Bierman P; Armitage JO; Bociek RG
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):392-7. PubMed ID: 23773450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
    Gerber NK; Atoria CL; Elkin EB; Yahalom J
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of nodular lymphocyte-predominant Hodgkin lymphoma-"do no harm".
    Bartlett NL
    Clin Adv Hematol Oncol; 2013 Jun; 11(6):385-7. PubMed ID: 24472810
    [No Abstract]   [Full Text] [Related]  

  • 20. Strategies to diagnose lymphoproliferative disorders by fine-needle aspiration by using ancillary studies.
    Caraway NP
    Cancer; 2005 Dec; 105(6):432-42. PubMed ID: 16222688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.